lamivudine has been researched along with BLV Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balestrieri, E; Forte, G; Macchi, B; Mastino, A; Matteucci, C | 1 |
| García-Lerma, JG; Heneine, W; Nidtha, S | 1 |
| Machuca, A; Rodés, B; Soriano, V | 1 |
1 trial(s) available for lamivudine and BLV Infections
| Article | Year |
|---|---|
The effect of antiretroviral therapy on HTLV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deltaretrovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; HIV-1; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Lamivudine; Male; Middle Aged; Proviruses; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2001 |
2 other study(ies) available for lamivudine and BLV Infections
| Article | Year |
|---|---|
Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro.
Topics: Anti-HIV Agents; Coculture Techniques; Deltaretrovirus Infections; DNA, Viral; Human T-lymphotropic virus 1; Humans; Lamivudine; Monocytes; Virus Replication | 2002 |
Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
Topics: Amino Acid Sequence; Deltaretrovirus Infections; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Human T-lymphotropic virus 1; Humans; Lamivudine; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 2001 |